271 related articles for article (PubMed ID: 32690231)
1. The severe COVID-19: A sepsis induced by viral infection? And its immunomodulatory therapy.
Lin HY
Chin J Traumatol; 2020 Aug; 23(4):190-195. PubMed ID: 32690231
[TBL] [Abstract][Full Text] [Related]
2. Advice regarding COVID-19 and use of immunomodulators, in patients with severe dermatological diseases.
Rademaker M; Baker C; Foley P; Sullivan J; Wang C
Australas J Dermatol; 2020 May; 61(2):158-159. PubMed ID: 32219857
[No Abstract] [Full Text] [Related]
3. Expert recommendations for the management of autoimmune bullous diseases during the COVID-19 pandemic.
Kasperkiewicz M; Schmidt E; Fairley JA; Joly P; Payne AS; Yale ML; Zillikens D; Woodley DT
J Eur Acad Dermatol Venereol; 2020 Jul; 34(7):e302-e303. PubMed ID: 32333823
[No Abstract] [Full Text] [Related]
4. Comparison of clinical laboratory tests between bacterial sepsis and SARS-CoV-2-associated viral sepsis.
Ren C; Yao RQ; Ren D; Li Y; Feng YW; Yao YM
Mil Med Res; 2020 Aug; 7(1):36. PubMed ID: 32753048
[TBL] [Abstract][Full Text] [Related]
5. Clinical features and development of sepsis in patients infected with SARS-CoV-2: a retrospective analysis of 150 cases outside Wuhan, China.
Ren D; Ren C; Yao RQ; Feng YW; Yao YM
Intensive Care Med; 2020 Aug; 46(8):1630-1633. PubMed ID: 32415313
[No Abstract] [Full Text] [Related]
6. Immunotherapies for COVID-19: lessons learned from sepsis.
Remy KE; Brakenridge SC; Francois B; Daix T; Deutschman CS; Monneret G; Jeannet R; Laterre PF; Hotchkiss RS; Moldawer LL
Lancet Respir Med; 2020 Oct; 8(10):946-949. PubMed ID: 32444269
[No Abstract] [Full Text] [Related]
7. The Use of "Novel Pharmacology" in the Treatment of COVID-19 and Potential Psychiatric Risks.
Yahya AS; Khawaja S; Chukwuma J
Prim Care Companion CNS Disord; 2020 May; 22(3):. PubMed ID: 32441496
[No Abstract] [Full Text] [Related]
8. Clinical characteristics of foreign-imported COVID-19 cases in Shanghai, China.
Liu XH; Lu SH; Chen J; Xia L; Yang ZG; Charles S; Yang Y; Lin Y; Lu HZ
Emerg Microbes Infect; 2020 Dec; 9(1):1230-1232. PubMed ID: 32515651
[No Abstract] [Full Text] [Related]
9. Thromboinflammatory response in SARS-CoV-2 sepsis.
Maiese A; Passaro G; Matteis A; Fazio V; Raffaele R; Paolo MD
Med Leg J; 2020 Jul; 88(2):78-80. PubMed ID: 32490726
[TBL] [Abstract][Full Text] [Related]
10. Asthma, biologics, corticosteroids, and coronavirus disease 2019.
Akenroye AT; Wood R; Keet C
Ann Allergy Asthma Immunol; 2020 Jul; 125(1):12-13. PubMed ID: 32387535
[No Abstract] [Full Text] [Related]
11. Can Levamisole be used in the treatment of COVID-19 patients presenting with diarrhea?
Uyaroğlu OA; Güven GS; Güllü İ
J Infect Dev Ctries; 2020 Aug; 14(8):844-846. PubMed ID: 32903227
[TBL] [Abstract][Full Text] [Related]
12. Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic.
; Jacob S; Muppidi S; Guidon A; Guptill J; Hehir M; Howard JF; Illa I; Mantegazza R; Murai H; Utsugisawa K; Vissing J; Wiendl H; Nowak RJ
J Neurol Sci; 2020 May; 412():116803. PubMed ID: 32247193
[No Abstract] [Full Text] [Related]
13. Assessment and management of adults with asthma during the covid-19 pandemic.
Beaney T; Salman D; Samee T; Mak V
BMJ; 2020 Jun; 369():m2092. PubMed ID: 32513811
[No Abstract] [Full Text] [Related]
14. Hyper-inflammatory Syndrome in a Child With COVID-19 Treated Successfully With Intravenous Immunoglobulin and Tocilizumab.
Balasubramanian S; Nagendran TM; Ramachandran B; Ramanan AV
Indian Pediatr; 2020 Jul; 57(7):681-683. PubMed ID: 32393681
[No Abstract] [Full Text] [Related]
15. COVID-19 as a cause of immune thrombocytopenia.
Humbert S; Razanamahery J; Payet-Revest C; Bouiller K; Chirouze C
Med Mal Infect; 2020 Aug; 50(5):459-460. PubMed ID: 32445664
[No Abstract] [Full Text] [Related]
16. Treatment of COVID-19-exacerbated asthma: should systemic corticosteroids be used?
Kumar K; Hinks TSC; Singanayagam A
Am J Physiol Lung Cell Mol Physiol; 2020 Jun; 318(6):L1244-L1247. PubMed ID: 32401670
[TBL] [Abstract][Full Text] [Related]
17. Perspective of the Surviving Sepsis Campaign on the Management of Pediatric Sepsis in the Era of Coronavirus Disease 2019.
Weiss SL; Peters MJ; Agus MSD; Alhazzani W; Choong K; Flori HR; Inwald DP; Nadel S; Nunnally ME; Schlapbach LJ; Tasker RC; Tissieres P; Kissoon N;
Pediatr Crit Care Med; 2020 Nov; 21(11):e1031-e1037. PubMed ID: 32886460
[TBL] [Abstract][Full Text] [Related]
18. Dysregulated adaptive immune response contributes to severe COVID-19.
Yu K; He J; Wu Y; Xie B; Liu X; Wei B; Zhou H; Lin B; Zuo Z; Wen W; Xu W; Zou B; Wei L; Huang X; Zhou P
Cell Res; 2020 Sep; 30(9):814-816. PubMed ID: 32759967
[No Abstract] [Full Text] [Related]
19. High-Dose Intravenous Immunoglobulins in the Treatment of Severe Acute Viral Pneumonia: The Known Mechanisms and Clinical Effects.
Liu X; Cao W; Li T
Front Immunol; 2020; 11():1660. PubMed ID: 32760407
[TBL] [Abstract][Full Text] [Related]
20. Understanding the complexities of SARS-CoV2 infection and its immunology: A road to immune-based therapeutics.
Kumar V
Int Immunopharmacol; 2020 Nov; 88():106980. PubMed ID: 33182073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
